Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market Forecasts to 2028 – Global Analysis By Technique (Traditional, Molecular), End User (Hospitals & Clinics, Diagnostic Reference Laboratories, Academic Research Institutes) and By Geography

4.8 (48 reviews)
Published: February 2022 ID: SMRC18296
4.8 (48 reviews)
Published: February 2022 ID: SMRC18296

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $28.10 billion in 2021 and is expected to reach $52.03 billion by 2028 growing at a CAGR of 9.2% during the forecast period. Disease diagnostics are used for confirmation of a disease in form of a quick, precise test result. The infectious disease epidemics are exploding worldwide, raising an extensive demand for diagnostic tests.

Market Dynamics:


Rising prevalence of infectious diseases

The prevalence of infectious diseases in developed and developing regions will positively influence the growth of the infectious disease diagnostics market. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for infectious disease diagnostics during the forecast period. The broad-scale population-based testing is required to improve prevention and control efforts for COVID-19. These tests are performed by infectious disease diagnostics. Hence, it is expected to have a positive impact on this market.


Inadequate reimbursement

Inadequate reimbursement is a major factor restraining the growth of the infectious disease diagnostics market. A major challenge that most diagnostic companies face in commercializing their tests is getting health insurers to pay for them.


Opportunities from developing economies

Developing economies such as India and South Korea are expected to offer potential growth opportunities for major players operating in the infectious disease diagnostics market. This can be attributed to the high disease prevalence, large patient population, improving healthcare infrastructure, increasing disposable income, and growing medical tourism in these countries. In addition to the factors mentioned above, the Asia Pacific has emerged as an adaptive and business-friendly hub due to relatively less stringent regulations and data requirements.


Poor distribution channel

Diagnostic kits are expensive and manufacturers still have poor distribution channel for operating across emerging economies. These two factors are projected to be the key challenges to rapid revenue growth of the global infectious diseases diagnostics market.

The reagents, kits, and consumables segment is expected to be the largest during the forecast period

The reagents, kits, and consumables segment is expected to be the largest during the forecast period owing to the factors such as increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost. Further, the outbreak of coronavirus (COVID-19) disease is further expected to accelerate the growth of this segment owing to the national emergency declared and requirement of various kits and assays for early disease detection.
The traditional segment is expected to have the highest CAGR during the forecast period

The dominance of traditional segment is mainly attributed to factors such as the increasing use of immunoassays in infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about health and fitness, and reduced complications associated with the instruments.

Region with largest share:

North America is projected to hold the largest market share owing to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments. Other factors contributing to the market growth are the increasing prevalence of infectious diseases and high expenditure on healthcare, and an increase in awareness among the population regarding the availability of treatment devices.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to the rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.

Key players in the market

Some of the key players profiled in the Infectious Disease Diagnostics Market include Becton, Dickinson and Company (BD), Abbott Diagnostic, Beckman Coulter, Siemens Healthcare Diagnostics, Roche Diagnostic, Thermo Fisher Scientific, Bio-Rad Laboratories, Meridian Bioscience, Corgenix, Trinity Biotech, Eiken Chemical, J.Mitra, Diasorin, EMD Millipore, and QuantuMDx. 

Key developments:

In July 2021: QuantuMDx launched the rapid polymerase chain reaction point-of-care diagnostic system called Q-POC for COVID-19.

In March 2021: Roche Diagnostics Launched cobas SARS-CoV-2 Variant Set 1 Test to help monitor emerging coronavirus mutations.

In February 2021: Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.

Products Covered:
• Reagents, Kits, and Consumables
• Instruments & Systems
• Software & Services

Test Types Covered:
• Laboratory Tests
• Imaging Test
• Point-of-Care (POC) Testing

Disease Types Covered:
• Bacterial Infection (Methicillin-resistant Staphylococcus Aureus (MRSA))
• Viral Infection
• Hepatitis C
• Hepatitis B
• Cardiovascular Infection
• Fungal Infection
• Hospital Acquired Infections (HAIs)
• Respiratory Infections
• Blood Infections
• Diarrheal Disease
• Central Nervous System (CNS) Infection
• Sexually Transmitted Diseases

Techniques Covered:
• Traditional
• Molecular

End Users Covered:
• Hospitals & Clinics
• Diagnostic Reference Laboratories
• Academic Research Institutes
• Home Healthcare
• Physician Offices
• Contract Research Organization
• Surgical Centers

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.